CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
28.97
14-June-24 14:59:59
15 minutes delayed
Stocks
-2.54
-8.06%
Today's range
28.26 - 31.26
ISIN
N/A
Source
NASDAQ
-
15 Feb 2022 15:05:00 By Nasdaq GlobeNewswire
-
08 Feb 2022 15:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Final Results of Previously Announced Tender Offer
20 Dec 2021 15:05:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer
16 Dec 2021 07:00:02 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Waiver of Condition to its Tender Offer for Common Shares
15 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Extension of Previously Announced Tender Offer
08 Dec 2021 07:00:01 By Nasdaq GlobeNewswire
-
08 Nov 2021 07:30:01 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Third Quarter Financial Results And Provides Corporate Update
03 Nov 2021 15:05:02 By Nasdaq GlobeNewswire
-
27 Oct 2021 15:05:01 By Nasdaq GlobeNewswire
-
17 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
William Guyer to join Corcept as Chief Development Officer
12 Aug 2021 16:00:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
29 Jul 2021 15:05:03 By Nasdaq GlobeNewswire
-
12 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
22 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Sun Pharmaceutical
15 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
10 Jun 2021 06:30:00 By Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Clinical Update and Announces First Quarter 2021 Financial Results
06 May 2021 15:10:00 By Nasdaq GlobeNewswire
-
06 May 2021 15:01:01 By Nasdaq GlobeNewswire